HBM Healthcare Investments
Capital Type
Venture Capital
Investment Size
Undisclosed / varies by deal
Geographic Scope
Global
Return Model
Dilutive
Stage Focus
Growth, Late venture, Public / crossover
Modality Focus
Diagnostics, Growth capital
Overview
Swiss healthcare investor with a diversified private and public portfolio and documented exposure to infectious-disease diagnostics.
Portfolio and Signals
Included because of its Karius position, making it a credible growth-stage investor for leading infection diagnostics companies.
Access and Engagement
Access is generally via later-stage rounds and high-signal syndicates.
Notable AMR Examples / Programs
Karius
Stay Updated
Stay connected so that you don't miss the latest AMR insights and updates.
